Adia Med, Inc.
ADIA· OTC
ADIAAdia Med, Inc.
Filed Aug 13, 2026 · 10-Q · 44 days after period end · 0001683168-26-006313
| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Revenue | $485.39K | $118.15K |
| Net Income | $40.42K | -$124.00K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adia Med, Inc. · CIK 1160420 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end
